TMO
THERMO FISHER SCIENTIFIC INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$701.77
+0.49%Year over year
Reported trailing growth
- Revenue
- +8.3%
- EBITDA
- -0.8%
- EBIT
- +5.1%
- EPS
- +9.5%
- Free cash flow
- +24.3%
- Operating cash flow
- +21.9%
Forward estimates
Based on analyst estimates
- Revenue
- +5.0%
- EBITDA
- +38.5%
- EPS
- +41.9%
Three-year CAGR
- Revenue
- -0.3%
- EBITDA
- -1.3%
- EBIT
- -1.7%
- Net income
- -1.0%
- EPS
- +0.1%
- Free cash flow
- -3.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026